You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
14 March 2014Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers
There has been significant effort over the past two decades in the treatment of malignancies of epithelial origin,
including some of the most devastating of cancers, such as colorectal cancer (CRC), squamous call carcinoma of the
head and neck (HNSCC), and carcinomas of the pancreas, lungs, (both Small Cell and Non-Small Cell), renal cell,
prostate, bladder and breast. Recurring, refractory HNSCC is a particularly difficult cancer to treat once the tumors
recur due to mutations that are resistant to repeat chemotherapy and radiation. In addition, repeat surgery is often
difficult due to the requirement of significant surgical margins that may not be possible due to the attending potential
functional deficits (e.g., salivary glands, nerves and major blood vessels in confined areas). In this study FaDu HNSCC
xenograft tumors in SCID mice were imaged, and “optical”, as opposed to “surgical” margins defined for the tumor
being treated. The subsequent two-photon treatment irradiation was computer-controlled to carry out the tumor
treatment by rastering the laser beam throughout the tumor volume plus the defined optical margins simultaneously. In
our initial studies, up to 85% regression in tumor volume was observed in 5 days post PDT, with complete tumor
regression in 18 days. No re-growth was observed up to 41 days post-PDT, with little or no scarring and complete hair
re-growth. However, competition between imaging and PDT moieties was also observed in some mouse models,
possibly favoring tumor re-growth. Strategies to selectively optimize the PDT effect will be discussed.
The alert did not successfully save. Please try again later.
Charles W. Spangler, Jean R. Starkey, Bo Liang, Sara Fedorka, Hao Yang, Huabei Jiang, "Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers," Proc. SPIE 8931, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIII, 89310C (14 March 2014); https://doi.org/10.1117/12.2043070